BPC157 | CAS 137525-51-0
- cas:137525-51-0
- Molecular Formula:C62H98N16O22
- Purity:≥98%(HPLC)
- Molecular Weight:1419.54 g/mol
Product Details
CasNo: 137525-51-0
Molecular Formula: C62H98N16O22
Appearance: White to off-white powder / lyophilized powder
Delivery Time: Confirmed according to order quantity, target specification, and current supply availability
Packing: Available according to order quantity and project requirements
Throughput: Evaluated based on project requirements, specifications, and order quantity
Purity: ≥98%(HPLC)
Product Overview
BPC-157, CAS 137525-51-0, is a synthetic research peptide composed of 15 amino acids. Its full sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
The one-letter sequence is GEPPPGKPADDAGLV.
BPC-157 is a well-defined synthetic pentadecapeptide with a molecular weight of approximately 1419.54 g/mol. Its relatively compact linear sequence makes it suitable for peptide identity confirmation, sequence characterization, HPLC and LC-MS method development, and related peptide R&D projects.
Shandong Juntai Pharmaceutical supports B2B sourcing of BPC-157 for research, analytical, and peptide development projects. Purity, product form, packaging, analytical data, and supporting documentation are confirmed according to the actual batch and project requirements.
Product Information
| Item | Information |
|---|---|
| Product Name | BPC-157 |
| CAS No. | 137525-51-0 |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.54 g/mol |
| Peptide Length | 15 amino acids |
| Peptide Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| One-Letter Sequence | GEPPPGKPADDAGLV |
| Product Type | Synthetic Pentadecapeptide |
| Category | Research Peptide |
| Appearance | White to off-white powder / lyophilized powder |
| Typical Purity | ≥98% by HPLC |
| Storage | Keep sealed, dry, and under low-temperature conditions |
| Main Use | Peptide research, structural characterization, analytical method development, and related R&D projects |
Product Features
Defined 15-Amino-Acid Sequence
BPC-157 contains 15 amino acid residues with the one-letter sequence GEPPPGKPADDAGLV.
The clearly defined sequence supports peptide identity testing, molecular-weight verification, purity assessment, and sequence-related analytical studies.
Relatively Simple Linear Peptide Structure
Compared with lipidated peptides, cyclic peptides, or molecules containing complex side-chain modifications, BPC-157 has a comparatively straightforward linear peptide structure.
This makes it suitable for work involving:
- Peptide identity confirmation
- Sequence-related characterization
- HPLC purity assessment
- MS / LC-MS analysis
- Peptide-related impurity studies
Suitable for Multi-Parameter Quality Characterization
For research peptides such as BPC-157, product quality should not be assessed by HPLC purity alone.
A more complete evaluation may include peptide identity, molecular weight, HPLC profile, MS / LC-MS data, sequence information, and product form.
For projects with defined analytical requirements, these parameters should be reviewed together with the actual batch documentation.
Product Form Should Be Confirmed Before Sourcing
Commercial BPC-157 materials may be represented in different counter-ion or product forms.
If a project requires a specific:
- Acetate form
- TFA-related form
- Counter-ion
- Molecular-weight range
- Analytical specification
the requested form should be confirmed during the inquiry stage to avoid mixing data from different product forms.
Research Applications
Peptide Structure and Sequence Research
BPC-157 can be used as a defined 15-amino-acid peptide in studies involving amino-acid composition, sequence characteristics, peptide structure, and related peptide analog research.
Peptide Identity and Quality Analysis
Its defined sequence and molecular information make BPC-157 suitable for:
- Molecular-weight confirmation
- HPLC purity analysis
- MS / LC-MS identity confirmation
- Sequence-related analytical studies
- Peptide-related impurity analysis
Analytical Method Development
BPC-157 may be used in analytical workflows involving:
- HPLC method development
- LC-MS method development
- Identity testing
- Purity evaluation
- Impurity profiling
- Analytical method verification
Research and R&D Projects
BPC-157 may also be used in peptide-related basic research and experimental projects.
Where biological mechanisms or experimental models are involved, study results should be interpreted within the specific research context rather than presented as established clinical effects.
Quality & Supply
BPC-157 projects generally require confirmation of product identity, purity, sequence, molecular weight, and product form.
| Quality Item | Typical Specification / Requirement |
|---|---|
| HPLC Purity | ≥98% |
| Identity | MS / LC-MS |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.54 g/mol |
| Peptide Length | 15 amino acids |
| Peptide Sequence | GEPPPGKPADDAGLV |
| Product Form | Confirmed according to project requirements |
| Appearance | White to off-white powder / lyophilized powder |
| Storage | Sealed, dry, and stored under low-temperature conditions |
A purity target of ≥98% by HPLC is commonly seen for research-grade commercial material. Final specifications should be based on the actual supply batch.
Shandong Juntai Pharmaceutical can discuss supply requirements based on target quantity, purity, packaging format, and analytical expectations.
For projects requiring specific HPLC, MS / LC-MS, product-form, packaging, or documentation requirements, those details can be provided during the inquiry stage for review.
Custom Peptide Support
Projects involving BPC-157 and related research peptides can be evaluated according to the target sequence and technical requirements.
Project discussions may include:
- BPC-157-related sequences
- Short-peptide synthesis
- Sequence truncation or extension
- N-terminal or C-terminal modifications
- Alternative counter-ion forms
- Target purity requirements
- HPLC / MS analytical requirements
- Related peptide analogs
- Project-specific quantity and packaging requirements
Feasibility is reviewed according to the target structure, required quantity, purity specification, and analytical expectations.
Frequently Asked Questions
What information should I provide when requesting BPC-157?
Please include the required quantity, target purity, preferred product form, packaging requirements, and analytical expectations.
If the project requires a specific counter-ion, HPLC, MS / LC-MS, or documentation package, those requirements should also be included in the inquiry.
What purity is commonly requested for BPC-157?
A common research-grade target is ≥98% by HPLC.
Actual available specifications should be confirmed according to the supply batch and project requirements.
Why should the product form be confirmed before purchasing BPC-157?
Different product forms may vary in counter-ion composition, molecular weight, and analytical behavior.
For projects with an established technical specification, confirming the exact product form before sourcing helps avoid specification mismatches.
Can COA, HPLC, or MS data be provided?
Availability of COA, HPLC, MS / LC-MS, and other analytical documentation depends on the actual batch and project requirements.
Specific documentation needs can be provided during the inquiry stage for confirmation.
What is the MOQ for BPC-157?
MOQ depends on the requested specification, quantity, packaging format, and current supply conditions.
Providing the expected purchase quantity helps determine an appropriate supply option.
How is BPC-157 packaged?
Packaging is selected according to order quantity, product specification, and project requirements.
Special packaging requirements can be discussed during the inquiry stage.
What is the typical lead time?
Lead time depends on the requested specification, order quantity, product form, and current supply status.
Projects involving special purity, analytical testing, or custom requirements may require a project-specific lead-time evaluation.
Can BPC-157-related sequences or custom peptides be evaluated?
Yes. Projects involving related sequences, terminal modifications, alternative product forms, or other peptide analogs can be reviewed based on the target structure, quantity, purity, and analytical requirements.
For research and development use only.
Relevant Products
-
Fmoc-Glu(OtBu)-Gly-Gly-OH
CAS:N/A
-
Semax
CAS:/
-
MOTS-c
CAS:/



